Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Crupi

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Iscience|August 13, 2025
Cargo-selective regulation of clathrin-mediated endocytosis by AMP-activated protein kinaseLaura A Orofiamma, Ralph Christian Delos Santos, Ayshin Mehrabi, et al.
Elife|April 30, 2024
Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamicsTimothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer ImmunotherapyNikolas T Martin, Mathieu J F Crupi, Zaid Taha, et al.
Molecular Therapy. Methods & Clinical Development|October 12, 2023
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Rida Gill, et al.
Membranes|September 3, 2020
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces TrimerizationTaha Azad, Ragunath Singaravelu, Mathieu J F Crupi, et al.
The Journal of Biological Chemistry|April 26, 2023
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral developmentStephen Boulton, Mathieu J F Crupi, Siddharth Singh, et al.
Public Health in Practice (Oxford, England)|September 12, 2022
Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly populationM A Kundro, M H Losso, A Macchia, et al.
International Journal of Molecular Sciences|March 6, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD InteractionEmily E F Brown, Reza Rezaei, Taylor R Jamieson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2021
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entryTaha Azad, Ragunath Singaravelu, Zaid Taha, et al.
Nature Communications|May 26, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapiesTaha Azad, Reza Rezaei, Ragunath Singaravelu, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Iscience|August 13, 2025
Cargo-selective regulation of clathrin-mediated endocytosis by AMP-activated protein kinaseLaura A Orofiamma, Ralph Christian Delos Santos, Ayshin Mehrabi, et al.
Elife|April 30, 2024
Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamicsTimothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer ImmunotherapyNikolas T Martin, Mathieu J F Crupi, Zaid Taha, et al.
Molecular Therapy. Methods & Clinical Development|October 12, 2023
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Rida Gill, et al.
Membranes|September 3, 2020
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces TrimerizationTaha Azad, Ragunath Singaravelu, Mathieu J F Crupi, et al.
The Journal of Biological Chemistry|April 26, 2023
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral developmentStephen Boulton, Mathieu J F Crupi, Siddharth Singh, et al.
Public Health in Practice (Oxford, England)|September 12, 2022
Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly populationM A Kundro, M H Losso, A Macchia, et al.
International Journal of Molecular Sciences|March 6, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD InteractionEmily E F Brown, Reza Rezaei, Taylor R Jamieson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2021
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entryTaha Azad, Ragunath Singaravelu, Zaid Taha, et al.
Nature Communications|May 26, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapiesTaha Azad, Reza Rezaei, Ragunath Singaravelu, et al.
Pageof 4